Organelle targeting: third level of drug targeting

References

• Jemal A Bray F Center MM Ferlay J Ward E Forman D Global cancer statistics CA Cancer J Clin 2011 61 2 69 90 21296855
   PubMed Web of Science ®Google Scholar
• Ferlay J Shin HR Bray F Forman D Mathers C Parkin DM Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 2010 127 12 2893 2917 21351269
   PubMed Web of Science ®Google Scholar
• Drabu S Khatri S Babu S Verma D Nanotechnology: An introduction to future drug delivery system J Chem Pharm Res 2010 2 1 171 179
   Google Scholar
• Chakraborty C Sarkar B Hsu CH Wen ZH Lin CS Shieh PC Future prospects of nanoparticles on brain targeted drug delivery J Neurooncol 2009 93 2 285 286 19048187
   PubMed Web of Science ®Google Scholar
• Ulbrich W Lamprecht A Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases J R Soc Interface 2010 7 Suppl 1 S55 S66 19940000
   PubMed Web of Science ®Google Scholar
• Wikberg M Ulmius J Ragnarsson G Review article: Targeted drug delivery in treatment of intestinal diseases Aliment Pharmacol Ther 1997 11 Suppl 3 109 115 9467985
   PubMed Web of Science ®Google Scholar
• Muller PY Milton MN The determination and interpretation of the therapeutic index in drug development Nat Rev Drug Discov 2012 11 10 751 761 22935759
   PubMed Web of Science ®Google Scholar
• Danhier F Feron O Préat V To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery J Control Release 2010 148 2 135 146 20797419
   PubMed Web of Science ®Google Scholar
• Sapra P Tyagi P Allen TM Ligand-targeted liposomes for cancer treatment Curr Drug Deliv 2005 2 4 369 381 16305440
   PubMedGoogle Scholar
• Wang X Yang L Chen Z Shin DM Application of nanotechnology in cancer therapy and imaging CA Cancer J Clin 2008 58 2 97 110 18227410
   PubMed Web of Science ®Google Scholar
• D’Souza G Weissig V An introduction to subcellular nanomedicine: current trends and future developments Weissig W D’Souza GGM Organelle-Specific Pharmaceutical Nanotechnology Hoboken, NJ John Wiley & Sons, Inc 2010 1 13
   Google Scholar
• Kang B Mackey MA El-Sayed MA Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis J Am Chem Soc 2010 132 5 1517 1519 20085324
   PubMed Web of Science ®Google Scholar
• de la Fuente JM Berry CC Tat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleus Bioconjug Chem 2005 16 5 1176 1180 16173795
   PubMed Web of Science ®Google Scholar
• Flierl A Jackson C Cottrell B Murdock D Seibel P Wallace DC Targeted delivery of DNA to the mitochondrial compartment via import sequence-conjugated peptide nucleic acid Mol Ther 2003 7 4 550 557 12727119
   PubMed Web of Science ®Google Scholar
• Lai S Hida K Man ST Privileged delivery of polymer nanoparticles to the perinuclear region of live cells via a non-clathrin, non-degradative pathway Biomaterials 2007 28 18 2876 2884 17363053
   PubMed Web of Science ®Google Scholar
• Rajendran L Knölker HJ Simons K Subcellular targeting strategies for drug design and delivery Nat Rev Drug Discov 2010 9 1 29 42 20043027
   PubMed Web of Science ®Google Scholar
• Cheng SM Boddapati SV D’Souza G Weissig V DQAsomes as mitochondria-targeted nanocarriers for anti-cancer drugs Nanotechnology for Cancer Therapy Boca Raton, FL CRC/Taylor and Francis 2006 787 802
   Google Scholar
• Bareford L Swaan PW Endocytic mechanisms for targeted drug delivery Adv Drug Deliv Rev 2007 59 8 748 758 17659804
   PubMed Web of Science ®Google Scholar
• Neekhra N Padh H An insight into molecular mechanism of endocytosis Indian J Biochem Biophys 2004 41 2–3 69 80 22900333
   PubMed Web of Science ®Google Scholar
• García-García E Rosales C Signal transduction during Fc receptor-mediated phagocytosis J Leukoc Biol 2002 72 6 1092 1108 12488490
   PubMed Web of Science ®Google Scholar
• Aderem A Underhill DM Mechanisms of phagocytosis in macrophages Annu Rev Immunol 1999 17 593 623 10358769
   PubMed Web of Science ®Google Scholar
• Dominska M Dykxhoorn DM Breaking down the barriers: siRNA delivery and endosome escape J Cell Sci 2010 123 Pt 8 1183 1189 20356929
   PubMed Web of Science ®Google Scholar
• Greish K Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting Methods Mol Biol 2010 624 25 37 20217587
   PubMedGoogle Scholar
• Maeda H Fang J Inutsuka T Kitamoto Y Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications Int Immunopharmacol 2003 3 3 319 328 12639809
   PubMed Web of Science ®Google Scholar
• Wu HC Chang DK Peptide-mediated liposomal drug delivery system targeting tumor blood vessels in anticancer therapy J Oncol 2010 2010 723798 20454584
   PubMedGoogle Scholar
• Jagadale R Sakhrani N Padh H Drug delivery and drug targeting using therapeutic nanoparticles Nanotechnology: Present Status and Future Prospects in Developing Countries New Delhi Daya Publishing House 2011 110 132
   Google Scholar
• Vasir J Reddy M Labhasetwar V Nanosystems in drug targeting: opportunities and challenges Curr Nanosci 2005 1 1 47 64
   Web of Science ®Google Scholar
• Wilson A Zhou W Champion HC Targeted delivery of oligodeoxynucleotides to mouse lung endothelial cells in vitro and in vivo Mol Ther 2005 12 3 510 518 15953766
   PubMed Web of Science ®Google Scholar
• Mamot C Drummond DC Greiser U Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells Cancer Res 2003 63 12 3154 3161 12810643
   PubMed Web of Science ®Google Scholar
• Parker N Turk MJ Westrick E Lewis JD Low PS Leamon CP Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay Anal Biochem 2005 338 2 284 293 15745749
   PubMed Web of Science ®Google Scholar
• Biragyn A Ruffini PA Coscia M Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo Blood 2004 104 7 1961 1969 15191951
   PubMed Web of Science ®Google Scholar
• Li H Qian ZM Transferrin/transferrin receptor-mediated drug delivery Med Res Rev 2002 22 3 225 250 11933019
   PubMed Web of Science ®Google Scholar
• Gautam A Chaudhary K Kumar R Sharma A Kapoor P Tyagi A Open source drug discovery consortium, Raghava GPS In silico approaches for designing highly effective cell penetrating peptides Journal of Translational Medicine 2013 11 74 23517638
   PubMed Web of Science ®Google Scholar
• Lindgren M Hällbrink M Prochiantz A Langel U Cell-penetrating peptides Trends Pharmacol Sci 2000 21 3 99 103 10689363
   PubMed Web of Science ®Google Scholar
• Li Y Rosal RV Brandt-Rauf PW Fine RL Correlation between hydrophobic properties and efficiency of carrier-mediated membrane transduction and apoptosis of a p53 C-terminal peptide Biochem Biophys Res Commun 2002 298 3 439 449 12413961
   PubMed Web of Science ®Google Scholar
• Roeder GE Parish JL Stern PL Gaston K Herpes simplex virus VP22-human papillomavirus E2 fusion proteins produced in mammalian or bacterial cells enter mammalian cells and induce apoptotic cell death Biotechnol Appl Biochem 2004 40 Pt 2 157 165 14709162
   PubMed Web of Science ®Google Scholar
• Joliot A Pernelle C Deagostini-Bazin H Prochiantz A Antennapedia homeobox peptide regulates neural morphogenesis Proc Natl Acad Sci USA 1991 88 5 1864 1868 1672046
   PubMed Web of Science ®Google Scholar
• Futaki S Suzuki T Ohashi W Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery J Biol Chem 2001 276 8 5836 5840 11084031
   PubMed Web of Science ®Google Scholar
• Kersemans V Cornelissen B Targeting the tumour: cell penetrating peptides for molecular imaging and radiotherapy Pharmaceuticals 2010 3 3 600 620
   Google Scholar
• Vivès E Schmidt J Pèlegrin A Cell-penetrating and cell-targeting peptides in drug delivery Biochim Biophys Acta 2008 1786 2 126 138 18440319
   PubMed Web of Science ®Google Scholar
• Juliano RL Intracellular delivery of oligonucleotide conjugates and dendrimer complexes Ann NY Acad Sci 2006 1082 18 26 17145920
   PubMed Web of Science ®Google Scholar
• Schwarze SR Ho A Vocero-Akbani A Dowdy SF In vivo protein transduction: delivery of a biologically active protein into the mouse Science 1999 285 5433 1569 1572 10477521
   PubMed Web of Science ®Google Scholar
• Muratovska A Eccles MR Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells FEBS Lett 2004 558 1–3 63 68 14759517
   PubMed Web of Science ®Google Scholar
• Bian J Popovic ZB Benejam C Kiedrowski M Rodriguez LL Penn MS Effect of cell-based intercellular delivery of transcription factor GATA4 on ischemic cardiomyopathy Circ Res 2007 100 11 1626 1633 17495229
   PubMed Web of Science ®Google Scholar
• Maniti O Blanchard E Trugnan G Lamazière A Ayala-Sanmartin J Metabolic energy-independent mechanism of internalization for the cell penetrating peptide penetratin Int J Biochem Cell Biol 2012 44 869 875 22387312
   PubMed Web of Science ®Google Scholar
• Fittipaldi A Ferrari A Zoppé M Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins J Biol Chem 2003 278 36 34141 34149 12773529
   PubMed Web of Science ®Google Scholar
• Kaplan IM Wadia JS Dowdy SF Cationic TAT peptide transduction domain enters cells by macropinocytosis J Control Release 2005 102 1 247 253 15653149
   PubMed Web of Science ®Google Scholar
• Tünnemann G Martin RM Haupt S Patsch C Edenhofer F Cardoso MC Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells FASEB J 2006 20 11 1775 1784 16940149
   PubMed Web of Science ®Google Scholar
• Madani F Lindberg S Langel Ü Futaki S Gräslund A Mechanisms of Cellular Uptake of Cell-Penetrating Peptides Journal of Biophysics 2011 1 10
   Google Scholar
• Duchardt F Fotin-Mleczek M Schwarz H Fischer R Brock R A comprehensive model for the cellular uptake of cationic cell-penetrating peptides Traffic 2007 8 7 848 866 17587406
   PubMed Web of Science ®Google Scholar
• Mo RH Zaro JL Shen W-C Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy Mol Pharm 2012 9 299 309 22171592
   PubMed Web of Science ®Google Scholar
• Saar K Lindgren M Hansen M Cell-penetrating peptides: a comparative membrane toxicity study Anal Biochem 2005 345 1 55 65 16137634
   PubMed Web of Science ®Google Scholar
• El-Andaloussi S Järver P Johansson HJ Langel U Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study Biochem J 2007 407 2 285 292 17627607
   PubMed Web of Science ®Google Scholar
• Pollard H Remy JS Loussouarn G Demolombe S Behr JP Escande D Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells J Biol Chem 1998 273 13 7507 7511 9516451
   PubMed Web of Science ®Google Scholar
• Lander ES Linton LM Birren B Initial sequencing and analysis of the human genome Nature 2001 409 6822 860 921 11237011
   PubMed Web of Science ®Google Scholar
• Venter JC Adams MD Myers EW The sequence of the human genome Science 2001 291 5507 1304 1351 11181995
   PubMed Web of Science ®Google Scholar
• Waterston RH Lindblad-Toh K Birney E Initial sequencing and comparative analysis of the mouse genome Nature 2002 420 6915 520 562 12466850
   PubMed Web of Science ®Google Scholar
• Peters MF Nucifora FCJr Kushi J Nuclear targeting of mutant Huntingtin increases toxicity Mol Cell Neurosci 1999 14 2 121 128 10479410
   PubMed Web of Science ®Google Scholar
• Yasuhara N Takeda E Inoue H Kotera I Yoneda Y Importin alpha/beta-mediated nuclear protein import is regulated in a cell cycle-dependent manner Exp Cell Res 2004 297 1 285 293 15194443
   PubMed Web of Science ®Google Scholar
• Macara IG Transport into and out of the nucleus Microbiol Mol Biol Rev 2001 65 4 570 594 11729264
   PubMed Web of Science ®Google Scholar
• Chan CK Jans DA Using nuclear targeting signals to enhance non-viral gene transfer Immunol Cell Biol 2002 80 2 119 130 11940112
   PubMed Web of Science ®Google Scholar
• Strunze S Trotman LC Boucke K Greber UF Nuclear targeting of adenovirus type 2 requires CRM1-mediated nuclear export Mol Biol Cell 2005 16 6 2999 3009 15814838
   PubMed Web of Science ®Google Scholar
• Nabi IR Le PU Caveolae/raft-dependent endocytosis J Cell Biol 2003 161 4 673 677 12771123
   PubMed Web of Science ®Google Scholar
• Li S Huang L Nonviral gene therapy: promises and challenges Gene ther 2000 7 1 31 34 10680013
   PubMed Web of Science ®Google Scholar
• Nabel GJ Nabel EG Yang ZY Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans Proc Natl Acad Sci USA 1993 90 23 11307 11311 8248244
   PubMed Web of Science ®Google Scholar
• Robbins J Dilworth SM Laskey RA Dingwall C Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence Cell 1991 64 3 615 623 1991323
   PubMed Web of Science ®Google Scholar
• Torchilin VP Levchenko TS Rammohan R Volodina N Papahadjopoulos-Sternberg B D’Souza GG Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes Proc Natl Acad Sci USA 2003 100 4 1972 1977 12571356
   PubMed Web of Science ®Google Scholar
• Kim J Dang CV Cancer’s Molecular Sweet Tooth and the Warburg Effect Cancer Research 2006 66 8927 8930 16982728
   PubMed Web of Science ®Google Scholar
• Warburg O On the origin of cancer cells Science 1956 123 3191 309 314 13298683
   PubMed Web of Science ®Google Scholar
• Costantini P Jacotot E Decaudin D Kroemer G Mitochondrion as a novel target of anticancer chemotherapy J Natl Cancer Inst 2000 92 13 1042 1053 10880547
   PubMed Web of Science ®Google Scholar
• Duchen MR Roles of mitochondria in health and disease Diabetes 2004 53 Suppl 1 S96 S102 14749273
   PubMed Web of Science ®Google Scholar
• Czarna M Jarmuszkiewicz W [Role of mitochondria in reactive oxygen species generation and removal; relevance to signaling and programmed cell death.] Postepy Biochem 2006 52 2 145 156 Polish [with English abstract] 17078504
   PubMedGoogle Scholar
• Murphy MP Smith RA Drug delivery to mitochondria: the key to mitochondrial medicine Adv Drug Deliv Rev 2000 41 2 235 250 10699318
   PubMed Web of Science ®Google Scholar
• Taylor RW Wardell TM Smith PM An antigenomic strategy for treating heteroplasmic mtDNA disorders Adv Drug Deliv Rev 2001 49 1–2 121 125 11377807
   PubMed Web of Science ®Google Scholar
• Weissig V Cheng SM D’Souza GG Mitochondrial pharmaceutics Mitochondrion 2004 3 4 229 244 16120357
   PubMed Web of Science ®Google Scholar
• Kidd JF Pilkington MF Schell MJ Paclitaxel affects cytosolic calcium signals by opening the mitochondrial permeability transition pore J Biol Chem 2002 277 8 6504 6510 11724773
   PubMed Web of Science ®Google Scholar
• Robertson JD Gogvadze V Zhivotovsky B Orrenius S Distinct pathways for stimulation of cytochrome c release by etoposide J Biol Chem 2000 275 42 32438 32443 10961984
   PubMed Web of Science ®Google Scholar
• André N Braguer D Brasseur G Paclitaxel induces release of cytochrome c from mitochondria isolated from human neuroblastoma cells Cancer Res 2000 60 19 5349 5353 11034069
   PubMed Web of Science ®Google Scholar
• Smith RA Porteous CM Coulter CV Murphy MP Selective targeting of an antioxidant to mitochondria Eur J Biochem 1999 263 3 709 716 10469134
   PubMedGoogle Scholar
• Abe Y Shodai T Muto T Structural basis of presequence recognition by the mitochondrial protein import receptor Tom20 Cell 2000 100 5 551 560 10721992
   PubMed Web of Science ®Google Scholar
• Stojanovski D Johnston AJ Streimann I Hoogenraad NJ Ryan MT Import of nuclear-encoded proteins into mitochondria Exp Physiol 2003 88 1 57 64 12525855
   PubMed Web of Science ®Google Scholar
• Tanaka M Borgeld HJ Zhang J Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria J Biomed Sci 2002 9 6 Pt 1 534 541 12372991
   PubMed Web of Science ®Google Scholar
• Weiss MJ Wong JR Ha CS Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation Proc Natl Acad Sci USA 1987 84 15 5444 5448 3474661
   PubMed Web of Science ®Google Scholar
• Weissig V Lasch J Erdos G Meyer HW Rowe TC Hughes J DQAsomes: a novel potential drug and gene delivery system made from Dequalinium Pharm Res 1998 15 2 334 337 9523323
   PubMed Web of Science ®Google Scholar
• Weissig V D’Souza GG Torchilin VP DQAsome/DNA complexes release DNA upon contact with isolated mouse liver mitochondria J Control Release 2001 75 3 401 408 11489326
   PubMed Web of Science ®Google Scholar
• D’Souza GG Boddapati SV Weissig V Mitochondrial leader sequence – plasmid DNA conjugates delivered into mammalian cells by DQAsomes co-localize with mitochondria Mitochondrion 2005 5 5 352 358 16154389
   PubMed Web of Science ®Google Scholar
• D’Souza GG Cheng SM Boddapati SV Horobin RW Weissig V Nanocarrier-assisted sub-cellular targeting to the site of mitochondria improves the pro-apoptotic activity of paclitaxel J Drug Target 2008 16 7 578 585 18686127
   PubMed Web of Science ®Google Scholar
• De Duve C Pressman BC Gianetto R Wattiaux R Appelmans F Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue Biochem. J 1955 60 4 604 617 13249955
   PubMed Web of Science ®Google Scholar
• Lübke T Lobel P Sleat DE Proteomics of the lysosome Biochim Biophys Acta 2009 1793 4 625 635 18977398
   PubMed Web of Science ®Google Scholar
• Bagshaw RD Mahuran DJ Callahan JW A proteomic analysis of lysosomal integral membrane proteins reveals the diverse composition of the organelle Mol Cell Proteomics 2005 4 2 133 143 15579476
   PubMed Web of Science ®Google Scholar
• Parkinson-Lawrence EJ Shandala T Prodoehl M Plew R Borlace GN Brooks DA Lysosomal storage disease: revealing lysosomal function and physiology Physiology (Bethesda) 2010 25 2 102 115 20430954
   PubMed Web of Science ®Google Scholar
• Cottrell GS Padilla BE Amadesi S Endosomal endothelin-converting enzyme-1: a regulator of beta-arrestin-dependent ERK signaling J Biol Chem 2009 284 33 22411 22425 19531493
   PubMed Web of Science ®Google Scholar
• Ni X Canuel M Morales CR The sorting and trafficking of lysosomal proteins Histol Histopathol 2006 21 8 899 913 16691542
   PubMed Web of Science ®Google Scholar
• Sly WS Vogler C Brain-directed gene therapy for lysosomal storage disease: going well beyond the blood-brain barrier Proc Natl Acad Sci USA 2002 99 9 5760 5762 11983877
   PubMed Web of Science ®Google Scholar
• Behnke J Eskelinen EL Saftig P Schröder B Two dileucine motifs mediate late endosomal/lysosomal targeting of transmembrane protein 192 (TMEM192) and a C-terminal cysteine residue is responsible for disulfide bond formation in TMEM192 homodimers Biochem J 2011 434 2 219 231 21143193
   PubMed Web of Science ®Google Scholar
• Grubb JH Vogler C Sly WS New strategies for enzyme replacement therapy for lysosomal storage diseases Rejuvenation Res 2010 13 2–3 229 236 20345279
   PubMed Web of Science ®Google Scholar
• Oliveira S van Rooy I Kranenburg O Storm G Schiffelers RM Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes Int J Pharm 2007 331 2 211 214 17187949
   PubMed Web of Science ®Google Scholar
• Ballestrero A Garuti A Cirmena G Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond Curr Cancer Drug Targets 2012 12 4 316 328 22385512
   PubMed Web of Science ®Google Scholar
• Chen J Huang XF Katsifis A Activation of signal pathways and the resistance to anti-EGFR treatment in colorectal cancer J Cell Biochem 2010 111 5 1082 1086 21053280
   PubMed Web of Science ®Google Scholar
• Neu M Fischer D Kissel T Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives J Gene Med 2005 7 8 992 1009 15920783
   PubMed Web of Science ®Google Scholar
• Khalil IA Kogure K Akita H Harashima H Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery Pharmacol Rev 2006 58 1 32 45 16507881
   PubMed Web of Science ®Google Scholar
• Boussif O Lezoualc’h F Zanta MA A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine Proc Natl Acad Sci USA 1995 92 16 7297 7301 7638184
   PubMed Web of Science ®Google Scholar
• Varkouhi AK Scholte M Storm G Haisma HJ Endosomal escape pathways for delivery of biologicals J Control Release 2011 151 3 220 228 21078351
   PubMed Web of Science ®Google Scholar
• Mazzarello P Bentivoglio M The centenarian Golgi apparatus Nature 1998 392 6676 543 544 9560144
   PubMed Web of Science ®Google Scholar
• Alberts B Johnson A Lewis J Raff M Roberts K Walter P Vesicular Traffic in the Secretory and Endocytic Pathways Molecular Biology of the Cell 4th ed New York, NY Garland 2002 1065 1126
   Google Scholar
• Aridor M Hannan LA Traffic jam: a compendium of human diseases that affect intracellular transport processes Traffic 2000 1 11 836 851 11208074
   PubMed Web of Science ®Google Scholar
• Wlodkowic D Skommer J McGuinness D Hillier C Darzynkiewicz Z ER-Golgi network – a future target for anti-cancer therapy Leuk Res 2009 33 11 1440 1447 19595459
   PubMed Web of Science ®Google Scholar
• Migita T Inoue S Implications of the Golgi apparatus in prostate cancer Int J Biochem Cell Biol 2012 44 11 1872 1876 22721754
   PubMed Web of Science ®Google Scholar
• Glinsky VV Glinsky GV Rittenhouse-Olson K The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium Cancer Res 2001 61 12 4851 4857 11406562
   PubMed Web of Science ®Google Scholar
• Boelens J Lust S Offner F Bracke ME Vanhoecke BW Review. The endoplasmic reticulum: a target for new anticancer drugs In Vivo 2007 21 2 215 226 17436569
   PubMed Web of Science ®Google Scholar
• Paschen W Frandsen A Endoplasmic reticulum dysfunction – a common denominator for cell injury in acute and degenerative diseases of the brain? J Neurochem 2001 79 4 719 725 11723164
   PubMed Web of Science ®Google Scholar
• Rutishauser J Spiess M Endoplasmic reticulum storage diseases Swiss Med Wkly 2002 132 17–18 211 222 12087487
   PubMed Web of Science ®Google Scholar
• Medeiros-Neto G Kim PS Yoo SE Congenital hypothyroid goiter with deficient thyroglobulin. Identification of an endoplasmic reticulum storage disease with induction of molecular chaperones J Clin Invest 1996 98 12 2838 2844 8981932
   PubMed Web of Science ®Google Scholar
• Pópulo H Lopes JM Soares P The mTOR signalling pathway in human cancer Int J Mol Sci 2012 13 12 1886 1918 22408430
   PubMed Web of Science ®Google Scholar
• Hanahan D Weinberg RA Hallmarks of cancer: the next generation Cell 2011 144 5 646 674 21376230
   PubMed Web of Science ®Google Scholar
• Drenan RM Liu X Bertram PG Zheng XF FKBP12-rapamycin-associated protein or mammalian target of rapamycin (FRAP/mTOR) localization in the endoplasmic reticulum and the Golgi apparatus J Biol Chem 2004 279 1 772 778 14578359
   PubMed Web of Science ®Google Scholar
• Liu X Zheng XF Endoplasmic reticulum and Golgi localization sequences for mammalian target of rapamycin Mol Biol Cell 2007 18 3 1073 1082 17215520
   PubMed Web of Science ®Google Scholar
• McCracken AA Brodsky JL Evolving questions and paradigm shifts in endoplasmic-reticulum-associated degradation (ERAD) Bio Essays 2003 25 868 877
   Web of Science ®Google Scholar
• Ye Y Diverse functions with a common regulator: ubiquitin takes command of an AAA ATPase J Struct Biol 2006 156 29 40 16529947
   PubMed Web of Science ®Google Scholar
• Wang Q Mora-Jensen H Weniger MA ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells Proc Natl Acad Sci USA 2009 106 7 2200 2205 19164757
   PubMed Web of Science ®Google Scholar
• Skubitz KM Phase II trial of pegylated-liposomal doxorubicin (Doxil) in mesothelioma Cancer Invest 2002 20 5–6 693 699 12197225
   PubMed Web of Science ®Google Scholar
• Fader AN Rose PG Abraxane for the treatment of gynecologic cancer patients with severe hypersensitivity reactions to paclitaxel Int J Gynecol Cancer 2009 19 7 1281 1283 19820391
   PubMed Web of Science ®Google Scholar
• Suzuki R Takizawa T Kuwata Y Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome Int J Pharm 2008 346 1–2 143 150 17640835
   PubMed Web of Science ®Google Scholar
• Wang YC Liu XQ Sun TM Xiong MH Wang J Functionalized micelles from block copolymer of polyphosphoester and poly(epsilon-caprolactone) for receptor-mediated drug delivery J Control Release 2008 128 1 32 40 18395283
   PubMed Web of Science ®Google Scholar
• Solomon M D’Souza GGM Approaches to achieving sub-cellular targeting of bioactives using pharmaceutical nanocarriers Prolop A Intracellular Delivery: Fundamental Biomedical Technologies New York, NY Springer 2011 57 72
   Google Scholar
• Kruth HS Jones NL Huang W Macropinocytosis is the endocytic pathway that mediates macrophage foam cell formation with native low density lipoprotein J Biol Chem 2005 280 3 2352 2360 15533943
   PubMed Web of Science ®Google Scholar
• Meier O Boucke K Hammer SV Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake J Cell Biol 2002 158 6 1119 1131 12221069
   PubMed Web of Science ®Google Scholar
• Ungewickell EJ Hinrichsen L Endocytosis: clathrin-mediated membrane budding Curr Opin Cell Biol 2007 19 4 417 425 17631994
   PubMed Web of Science ®Google Scholar
• Johnston APR Such GK Ng SL Caruso F Challenges facing colloidal delivery systems: from synthesis to the clinic Curr Opin Colloid Interface Sci 2011 16 3 171 181
   Web of Science ®Google Scholar
• McMahon HT Boucrot E Molecular mechanism and physiological functions of clathrin-mediated endocytosis Nat Rev Mol Cell Biol 2011 12 8 517 533 21779028
   PubMed Web of Science ®Google Scholar
• Pelkmans L Helenius A Endocytosis via caveolae Traffic 2002 3 5 311 320 11967125
   PubMed Web of Science ®Google Scholar
• Damm EM Pelkmans L Kartenbeck J Mezzacasa A Kurzchalia T Helenius A Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae J Cell Biol 2005 168 3 477 488 15668298
   PubMed Web of Science ®Google Scholar